Abstract
Gastric cancer is the most common cancer in Korea and constitutes 24.2% of all malignancies, 29.6% of male tumors, and 17.8% of female tumors [1]. The annual incidence is 69.1 per 100,000 in males and 29.5 per 100,000 in females. The prognosis for gastric carcinoma continues to be unfavorable in this country. The annual death rates are 38.8 per 100,000 for male and 23.9 per 100,000 for female. Surgery can result in cures or longer disease free survivals in only a small number of patients, since most gastric carcinomas are diagnosed when the tumor is at an advanced stage. More than 50% of all patients with newly diagnosed gastric carcinoma at the Seoul National University Hospital (SNUH) had an unresectable, locally advanced disease, and/or distant metastases (Figure 1). While response rates in gastric cancer patients treated with a combination chemotherapy regimen are somewhat better than for colorectal cancer, complete responses are generally uncommon. Thus far, the only treatment that results in a significant cure of gastric cancer is surgery. As the result of surgery depends upon the stage of disease, only early detection has been the best method to cure gastric cancer up to now. In this chapter, we intend to summarize the biologic and pathologic characteristics of gastric cancer, data of detection with radiologic and endoscopic measures, and the results of surgical treatment and chemotherapy regimens utilized at SNUH.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Anon, 1989. Ministry of Health and Social Affairs. Five years report for cancer register programme in the republic of Korea. July 1,1982–June 30,1987. J Korean Cancer Res Assoc 21:1.
Park JG, Frucht H, Larocca RV, et al., 1990. Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50:2773–2780.
Park JG, Kramer BS, Lai SL, et al., 1990. Chemosensitivity patterns and expression of human multidrug resistance (associated MDR1) gene by human gastric and colorectal cell lines. J Natl Cancer Inst, 82:193–198.
Le Chevalier T, Smith FP, Harter WK, et al., 1985. Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma. Semin Oncol 12:46–53.
Wils J, Bleiberg H, 1989. Current status of chemotherapy for gastric cancer. Eur J Cancer Clin Oncol 25:3–8.
Moertel CG, Rubin J, O’Connell MJ, et al., 1986. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of upper gastrointestinal adenocarci-noma. J Clin Oncol 4:1053–1057.
Arbuck SG, 1989. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 63:1036–1044.
Bleyer WA, 1989. New vistas for leucovorin in cancer chemotherapy. Cancer 63:995–1007.
Park JG, Collins JM, Gazdar AF, et al., 1988. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl Cancer Inst 80:1560–1564.
Berenberg JL, Goodman PJ, Oishi N, et al., 1989. 5-fluorouracil and folinic acid for the treatment of metastatic gastric cancer. Proc Am Soc Clin Oncol 8:101 (abstract).
Gottesman MM, Pastan I, 1988. The multidrug transporter, a double-edged sword. J Biol Chem 263:12163–12166.
Fojo AT, Akiyama SI, Gottesman MM, Pastan I, et al., 1985. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines. Cancer Res 45:3002–3007.
Fojo AT, Ueda K, Slamon DJ, et al., 1987. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265–269.
Thiebault F, Tsuruo T, Hamada H, et al., 1987. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735–7738.
Thiebault F, Tsuruo T, Hamada H. et al., 1988. Immunohistochemical localization in normal tissues of different epitopes in the mutidrug transport protein, pl70; Evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem, in press.
Goldstein LJ, Galski H, Fojo A, et al., 1989. Expression of a multidrug resistance gene in human tumors. J Natl Cancer Inst 81:116–124.
Moscow JA, Fairchild CR, Madden MJ, et al., 1989. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422–1428.
Yamauchi M, Satta T, Yaguchi T, et al., 1989. Expression of a multidrug-resistance gene and effectiveness of anticancer agents in human stomach and colon cancer cell lines. Proc Am Assoc Cancer Res 30:518 (abstract).
Pastan I, Gottesman MM 1987. Multiple drug resistance in human cancer. New Engl J Med 316:1388–1393.
Mukhopadhyay T, Batsakis JG, Kuo MT, 1988. Expression of the MDR(P-glycoprotein) gene in Chinese hamster digestive tracts. J Natl Cancer Inst 80:269–275.
Kim YI, 1987. Histogenesis of gastric carcinomas among Koreans: A histotopographic analysis of 2370 cases. Korean J Pathol 20 (abstract).
Kim YI, 1987. Significance of histologie ty** in gastric carcinoma: A useful parameter for prognostic determination and therapeutic implication. Korean J Gastroenterol 19:683–687.
Kim YI, Lee JB, 1977. A modified technique for pathologic approach in the investigation of early gastric cancer and chronic gastritis. J Korean Surg Soc 19:179–187.
Kim WH, Kim YI, 1988. Diagnostic accuracy of gastric endoscopie biopsy: Analysis of 818 gastric neoplasms with special reference to histologie discrepancy between endoscopie biopsy and resected stomach. Korean J Gastrointest Endoscopy 8:211–216.
Kim YI, Kim CJ, Kim WH. Histologie heterogeneity of gastric adenocarcinomas by depth of tumor invasion submitted for publication.
Oota K, Sobin LH, 1977. Histological ty** of gastric and oesophageal tumors. In International Classification of Tumors No. 18, Geneva: World Health Organization, pp. 15–41.
Shirakabe H, Ichikawa H, Kumakura K, et al., 1966. Atlas of X-ray diagnosis of early gastric cancer, Philadelphia: J.B. Lipincott Co., p. 1.
Gold RP, Green PH, O’Toole KM, et al., 1984. Early gastric cancer; radiographic experience. Radiology 152:283–290.
Kim JP, Park JG, Noh DY, et al., 1983. Early gastric cancer 137 cases. J Korean Cancer Res Assoc 15:42–49.
Choi BI, Kim JH, Han MC, et al., 1987. Radiological evaluation of early gastric cancer; analysis of 104 cases. J Korean Radiol Soc 23:424–431.
Shirakabe H, Maruyama M, 1982. Definition and classification of X-ray diagnosis of early gastric cancer. In (Shirakabe H, ed). Atlas of X-ray Diagnosis of Early Gastric Cancer. Tokyo: Igaku-Shoin, pp. 7–8.
Nishizawa M, Kariya, 1982. Diagnosis of gastric cancer. In (Shirakabe H, ed). Atlas of X-ray Diagnosis of Early Gastric Cancer. Tokyo: Igaku-Shoin, pp. 72–73.
Choi HJ, Moon YM, 1971. Endoscopic biopsy. Korean J Gastroenterol 4:1–7.
Takagi K, 1971. Limit of detection of minute gastric cancer of stomach cancer in mass survey. Gastroenterol Japonica 6:109.
Moon SE, 1985. A clinical analysis on adenocarcinoma of stomach. Pusan Medical J 25:83–95.
Cho MH, Park JG, Kim JP, 1989. Clinical evaluation of total gastrectomy and extended total gastrectomy for gastric cancer. J Korean Cancer Res Assoc 21:93–100.
Nishioka B, Watanabe S, Fujita Y, et al., 1979. Evaluation of resection of stomach and adjacent organs for advanced gastric cancer in special reference to splenectomy and pan-creaticosplenectomy. Jpn J Gastroenterol Surg 12:955–960.
Koga S, Kaibara N, Kimura O,et al., 1981. Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer. Am J Surg 142:546–550.
Suehiro S, Nagasue N, Ogawa Y, et al., 1984. The negative effect of splenectomy on the prognosis of gastric cancer. Am J Surg 148:645–648.
Kim SC, Kim SW, Bae SH, et al., 1989. The effect of splenectomy on the prognosis of gastric cancer. J Korean Cancer Res Assoc 21:74–81.
Chol SK, Park JG, Oh SK, et al., 1984. Esophagojejunostomy after total gastrectomy — Distal jejunal pouch. Korean J Gastroenterol 16:93–96.
Herfarth C, Schlag P, Buhl K, 1987. Surgical procedures for gastric substitution. World J Surg 11:689–698.
Yang HK, Park JG, Kim JP, 1989. Analysis of ten patients after total gastrectomy with jejunal interposition. Korean J Gastroenterol 21:76–80.
Oh ST, Kim JP, 1988. An analysis of lymph node metastasis of resected gastric carcinoma; 2467 cases. J Korean Surg Soc 35:145–151.
Kim JP, Park JG, 1983. Results of treatment of stomach cancer. J Korean Med Assoc 26:637–642.
Park JG, Kim JP, 1983. Reoperation for recurred stomach cancer. J Korean Cancer Res Assoc 15:64–69.
Lee CH, Park JG, Kim JP, 1987. Clinical study of reoperation for recurred stomach cancer. J Korean Cancer Res Assoc 19:107–113.
Preusser P, Achterrath W, Wilke H, et al., 1988. Chemotherapy of gastric cancer. Cancer Treat Rev 15:257–277.
Earl HM, Coombes RC, Schein PS, 1984. Cytotoxic chemotherapy for cancer of the stomach. Clin Oncol 3:351–369.
Cullinan SA, Moertel CG, Eleming TR, et al., 1985. A comparison of three chemothera-peutic regimens in the treatment of advanced pancreatic and gastric carcinoma: 5-fluorouracil vs 5-fluorouracil and doxorubicin vs 5-fluorouracil, doxorubicin, and mitomycin-c. JAMA 253:2061–2067.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Park, JG. et al. (1991). Gastric cancer in Korea: experience at the Seoul National University Hospital. In: Sugarbaker, P.H. (eds) Management of Gastric Cancer. Cancer Treatment and Research, vol 55. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3882-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3882-0_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6731-4
Online ISBN: 978-1-4615-3882-0
eBook Packages: Springer Book Archive